Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Vesalio Announces FDA Approval of the NeVa VS™ to Treat Cerebral Vasospasm After Aneurysmal Rupture
NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture. Delayed cerebral vasospasm is the leading cause of death and disability in patients who suffer an aneurysm rupture. - September 15, 2022 - Vesalio
NatureKue Introduces LiverSupport - Natural Dietary Supplement Supports Healthy Liver Function as It Reduces Fatty Deposits
NatureKue introduces LiverSupport, an herbal dietary supplement for adults who seek everyday support to help detoxify their liver, reduce accumulated fatty deposits in the liver, and help maintain healthy cholesterol and triglyceride levels. - September 06, 2022 - NatureKue
The Medical Center of Aurora Receives Prestigious Three-Star Rating from The Society of Thoracic Surgeons
The Medical Center of Aurora has earned a distinguished three-star rating from The Society of Thoracic Surgeons (STS) for its patient care and lung cancer resection outcomes. The three-star rating, which denotes the highest category of quality, places The Medical Center of Aurora among the elite... - August 31, 2022 - The Medical Center of Aurora
CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods
The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company
Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program
The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company
The Brooklyn Cancer Center Opens in Downtown Brooklyn
The Brooklyn Cancer Center (TBCC), a partnership between New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, and The Brooklyn Hospital Center (TBHC), an independent community hospital in Fort Greene/Downtown Brooklyn, marked a major milestone today... - August 25, 2022 - New York Cancer & Blood Specialists
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical
ClinicalPURSUIT’s State-of-the-Art EDC System Enables Researchers to Set Up Multicenter Studies in Weeks
The Missouri-based technology provider is helping clinical research and trials specialists set up multicenter studies in weeks through their technology. - August 19, 2022 - ClinicalPURSUIT
ClinicalPURSUIT is Transforming Clinical Research by Offering Powerful Data Capture Tools That Streamline Operations
The leading EDC technology provider is helping those involved in clinical research with powerful data capture tools that promote productivity and efficiency. - August 14, 2022 - ClinicalPURSUIT
NY Health Welcomes Urologist Raymond Khargi, MD
New York Health (NYHealth), the premier practice of primary and specialty care, is proud to announce the addition of board-certified urologist Raymond Khargi, MD. - August 03, 2022 - New York Health
New California Health Interview Survey (CHIS) COVID-19 Estimates Show Unvaccinated Adults Least Likely to Wear a Mask, Engage in Risk Reduction Behaviors
The UCLA Center for Health Policy Research's California Health Interview Survey has released preliminary COVID-19 estimates from April 2022, including responses to questions on risk reduction behaviors, such as masking, following state guidelines, and gathering with people outside their households; experience with long COVID; reasons for not being vaccinated or getting the booster; personal and financial impacts, such as reduction in hours, job loss, trouble paying bills; and more. - August 03, 2022 - UCLA Center for Health Policy Research
Experienced Gynecologic Oncologist Albert J. Steren, MD, FACOG, Joins Maryland Oncology Hematology
An accomplished and respected Dr. Steren is a surgeon with over 30 years of experience in gynecology and gynecologic oncology, joins the Rockville division of Maryland Oncology Hematology. - August 01, 2022 - Maryland Oncology Hematology
IVI and AcademyHealth Launch Project to Improve Measurement of Patient Healthcare Costs
Ensuring meaningful change in value assessment means recognizing the full economic impacts of serious health conditions on patients and caregivers. - July 27, 2022 - Innovation and Value Initiative
NY Health Appoints Vice President of Primary Care
New York Health (NYHealth) appoints Regina Primm as its Vice President of Primary Care. Primm has proven to be a prominent leader with more than a decade of experience working in healthcare. https://nyhealth.com/admin/regina-primm/ “I am honored to be given the opportunity to lead NY... - July 22, 2022 - New York Cancer & Blood Specialists
Heartland Pharmacy Creates New Collaborative Care Program
Heartland Pharmacy is launching a new senior care program to promote collaborative care for advanced physical wellness. - July 21, 2022 - Heartland Pharmacy
Julia Harwood Promoted to Senior Vice President of Clinical Operations for New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) announced today the appointment of Julia Harwood to Senior Vice President of Clinical Operations. https://nycancer.com/news/julia-harwood-promoted-to-senior-vice-president-of-clinical-operations-for-new-york-cancer-and-blood-specialists Harwood... - July 20, 2022 - New York Cancer & Blood Specialists
Nick Giampaolo Appointed Senior Vice President of Operations for New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) announces the appointment of Nick Giampaolo to Senior Vice President of Operations. Giampaolo will oversee expansion efforts in collaboration with the Chief Executive Officer and Chief Operating... - July 20, 2022 - New York Cancer & Blood Specialists
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo
Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.
Team Arnav Foundation to Hold 3rd Annual Event
Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation
George Sotos, MD Named Practice President of Maryland Oncology Hematology
Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has elected George Sotos, MD as the new practice President. Dr. Sotos succeeds Dr. Joseph Haggerty as of June 1 and will serve a three-year term. Dr. Sotos practices... - July 06, 2022 - Maryland Oncology Hematology
Kalimullah Quadri, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the Nation, is pleased to announce that Kalimullah Quadri, MD has joined the team of oncologists-hematologists. He will be practicing at 447 Atlantic Avenue, Brooklyn, NY 11217, and 121 Dekalb Avenue,... - July 06, 2022 - New York Cancer & Blood Specialists
Aleksander Vayntraub, MD Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, is pleased to announce that board-certified radiation oncologist Aleksander Vayntraub, MD, has joined the team of radiation oncologists. He will be practicing at NYCBS sites in Setauket, Patchogue,... - July 06, 2022 - New York Cancer & Blood Specialists
TrialX Launches a DEI Toolkit Within iConnect Platform to Tackle Diversity Challenges in Clinical Trial Recruitment
To overcome barriers to participation of diverse populations in clinical trials, TrialX launches a toolkit for sponsors and sites to create an end to end multilingual experience for patients. - June 21, 2022 - TrialX
Lead Medical is Honored in 24th Annual Digital Health Awards® Spring 2022 Session
Lead Medical’s Cath Lab Reporting System was selected as a winner at the 24th annual Digital Health Awards® program which recognizes the world’s best digital health resources. Receiving a Merit Award for Connected Digital Health, Lead Medical became the only Chinese digital health company recognized in the list of winners for the Spring 2022 session. - June 18, 2022 - Lead Medical
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home
Isaac Health is a national provider of dementia care via a virtual platform from the safety of your home. They diagnose, treat, manage, and coordinate care for you in collaboration with your physician, loved ones, and/or senior living community - June 04, 2022 - Isaac Health
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute
Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase
Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics
ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit
The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute
ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station
The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl
LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic
Vesalio Announces the Completion of Enrollment in Its FDA IDE Clinical Study for Acute Ischemic Stroke
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke. - May 11, 2022 - Vesalio
The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS
The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute
Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek
Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute
Dr. Salar Khan is Due to be Featured on the Front Cover of 2022 Top 100 Doctors Magazine's Q1 Edition
Dr. Salar Khan is named "Doctor & Leader of the Year" and is being honored with Top 100 Doctors' "Lifetime Achievement Award in Medicine & Leadership" for the year 2022. - April 27, 2022 - Top100 Registry Inc.
PDD and Tri-Star Design Announce Healthcare Market Partnership
PDD and Tri-Star Design announced, today, a new partnership that will accelerate innovation, design and development for a rapidly expanding digital healthcare market. Founded in 1991, Tri-Star Design collaborates with innovative high-tech companies to provide turn-key design and development... - April 11, 2022 - Tri-Star Design, Inc.
Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition
The Web Marketing Association will name the best medical websites in the world as part of their 26th annual international WebAward Competition for Web site development. Medial Websites can be entered into consideration for the 2022 Best Medical Website and other medical-related WebAwards at www.webaward.org. - April 10, 2022 - Web Marketing Association
EndoSoft® Announces ISO 13485:2016 Certification
EndoSoft, a Leading Health IT Company, announced today that they received ISO 13485:2016 Quality Management System Certification for the design, development, integration, and support of Electronic Health Record (EHR) and Artificial Intelligence (AI) software products (Registered by SRI Quality... - April 01, 2022 - EndoSoft
The Medical Center of Aurora Recognized by the American College of Cardiology in the “Best Hospitals” Issue of U.S. News & World Report
The Medical Center of Aurora has been recognized by the American College of Cardiology in the “Best Hospitals” issue of U.S. News & World Report as the top ranked hospital in Colorado for providing outstanding care to heart patients. - March 29, 2022 - The Medical Center of Aurora
Experienced Hematologist and Medical Oncologist Harminder Sethi, MD joins Maryland Oncology Hematology
Dr. Sethi has over 18 years of experience, specializing in targeted and biological therapy. - March 29, 2022 - Maryland Oncology Hematology
David Zagzag, MD, Ph.D Celebrated as an Honored Member for 2022 by Strathmore's Who's Who Worldwide Publication
David Zagzag, MD, Ph.D. of Rego Park, New York has been recognized as an Honored Member for 2022 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and high level of success in the medical field. About David Zagzag, MD, Ph.D. David Zagzag, MD, Ph.D. is a... - March 29, 2022 - Strathmore Worldwide
Med Bed Technology Products Now Beginning to be Released to Public
What is a "med bed" and when are med beds coming? Although the release of med beds mentioned in various underground programs have not been released yet there are many med bed light frequency technologies and technology products now providing various health benefits to users. Hospital Direct Medical looks at Tesla Plasma Chambers, Terahertz Wands, Tesla Ozone Ray's, Anti Aging Bed Covers and other products are now available. - March 28, 2022 - Hospital Direct Medical Equipment Inc.
C.A.M.P Brings New Hope to Alzheimer’s and Dementia Patients
A recent study conducted of CAMP (Cognitive Assessment & Memory Program), a neuro-digital health platform, has yielded exciting results for those suffering from mild to moderate cognitive impairment. - March 17, 2022 - campformemory.com
PurerVita Ltd. Launches UK First Revolutionary Supplements for Pregnancy and Postpartum Recovery
Launch of PurerMama, A positive impact nutritional and wellness brand by doctors at The Baby Show, Excel London. - March 12, 2022 - PurerVita UK Limited
Healthy Hope - Documentary Film Premieres at the Amelia Island Film Festival
The documentary "Healthy Hope" will makes its premiere Saturday, February 25, 2022 at the Amelia Island Film Festival in Florida. The film is about the research being done on the cancer fighting & curative properties of the Muscadine Grape. Doctors from NC State, Wake Forest University, Howard University, Morgan State University, and Johns Hopkins University talk about the results they have seen in their studies. - February 25, 2022 - CLINNEAM LLC
FOXG1 Research Foundation Hosts Napa Valley Charity Golf Tournament to Accelerate Research for Pediatric Neurological Disorder
Scientists believe FOXG1 may hold the key to unlocking brain disorders affecting millions, including autism, Alzheimer’s, brain tumors and more. - February 23, 2022 - FOXG1 Research Foundation
2022 Women in Oncology Awards
The Women in Oncology Awards are presented annually to outstanding women who have made remarkable contributions to the lives of those fighting cancer. The winners of the 2022 Women in Oncology Awards are Karen Kelly, MD, FASCO, Elizabeth A. Mittendorf, MD, PhD, and Rachna T. Shroff, MD, MS. - February 23, 2022 - Cancer Expert Now, Inc.
FOXG1 Research Foundation’s Hourinaz Behesti PhD to Present at BIO CEO & Investor Conference 2022
The FOXG1 Research Foundation, the rare disease patient organization that is driving the science to find treatments for FOXG1 syndrome, will be presenting at the BIO CEO & Conference on February 14 to discuss Tapping into Therapeutic Development for Rare CNS Disorders. Dir. of Science, Hourinaz Behesti will discuss why FOXG1 is a viable target for biotech investment, and the suite of assets that the FRF has developed and characterized to help accelerate drug development. - February 09, 2022 - FOXG1 Research Foundation